{"entity":{"type":"insider","cik":"0001531563","url":"/insider/0001531563","json_url":"/insider/0001531563.json","name":"Mulroy Robert J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":6,"first":"2013-12-05","last":"2015-03-25","span_basis":"filed_date"},"name_variants":[{"name":"Mulroy Robert J.","source":"filing","n_filings":6,"first_seen":"2013-12-05","last_seen":"2015-03-25"}],"transactions":[{"id":8529141,"accession":"0001179110-15-005436","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-15-005436","line_url":"/filing/0001179110-15-005436#line-7","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531563","owner_name":"Mulroy Robert J.","owner_display_name":"Mulroy Robert J.","owner_url":"/insider/0001531563","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103968.0,"shares_display":"103,968","price_per_share":11.71,"price_display":"11.71","price_state":"stated","total_value":1217465.28,"total_display":"1,217,465.28","total_whole":"1,217,465","shares_owned_after":1509316.0,"shares_owned_after_display":"1,509,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-24","filed_date":"2015-03-25","scope":"insider"},{"id":8529120,"accession":"0001179110-15-005436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-005436","line_url":"/filing/0001179110-15-005436#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531563","owner_name":"Mulroy Robert J.","owner_display_name":"Mulroy Robert J.","owner_url":"/insider/0001531563","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10400.0,"shares_display":"10,400","price_per_share":11.69,"price_display":"11.69","price_state":"stated","total_value":121576.0,"total_display":"121,576.00","total_whole":"121,576","shares_owned_after":1339316.0,"shares_owned_after_display":"1,339,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-23","filed_date":"2015-03-25","scope":"insider"},{"id":8151835,"accession":"0001179110-15-004510","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-004510","line_url":"/filing/0001179110-15-004510#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531563","owner_name":"Mulroy Robert J.","owner_display_name":"Mulroy Robert J.","owner_url":"/insider/0001531563","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22385.0,"shares_display":"22,385","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":279812.5,"total_display":"279,812.50","total_whole":"279,813","shares_owned_after":1339316.0,"shares_owned_after_display":"1,339,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-09","scope":"insider"},{"id":8931071,"accession":"0001179110-15-003044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-003044","line_url":"/filing/0001179110-15-003044#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531563","owner_name":"Mulroy Robert J.","owner_display_name":"Mulroy Robert J.","owner_url":"/insider/0001531563","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":10.94,"price_display":"10.94","price_state":"stated","total_value":1641000.0,"total_display":"1,641,000.00","total_whole":"1,641,000","shares_owned_after":1339316.0,"shares_owned_after_display":"1,339,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-20","filed_date":"2015-02-20","scope":"insider"},{"id":6368841,"accession":"0001179110-14-017783","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-14-017783","line_url":"/filing/0001179110-14-017783#line-6","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531563","owner_name":"Mulroy Robert J.","owner_display_name":"Mulroy Robert J.","owner_url":"/insider/0001531563","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":9.73,"price_display":"9.73","price_state":"stated","total_value":243250.0,"total_display":"243,250.00","total_whole":"243,250","shares_owned_after":1270232.0,"shares_owned_after_display":"1,270,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-08","filed_date":"2014-12-09","scope":"insider"},{"id":6368832,"accession":"0001179110-14-017783","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-017783","line_url":"/filing/0001179110-14-017783#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531563","owner_name":"Mulroy Robert J.","owner_display_name":"Mulroy Robert J.","owner_url":"/insider/0001531563","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":175000.0,"shares_display":"175,000","price_per_share":9.85,"price_display":"9.85","price_state":"stated","total_value":1723750.0,"total_display":"1,723,750.00","total_whole":"1,723,750","shares_owned_after":1246069.0,"shares_owned_after_display":"1,246,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-05","filed_date":"2014-12-09","scope":"insider"},{"id":6547666,"accession":"0001179110-14-007829","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-007829","line_url":"/filing/0001179110-14-007829#line-1","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531563","owner_name":"Mulroy Robert J.","owner_display_name":"Mulroy Robert J.","owner_url":"/insider/0001531563","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.31,"price_display":"6.31","price_state":"stated","total_value":31550.0,"total_display":"31,550.00","total_whole":"31,550","shares_owned_after":946069.0,"shares_owned_after_display":"946,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-05","filed_date":"2014-05-07","scope":"insider"},{"id":5523813,"accession":"0001179110-13-017459","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-017459","line_url":"/filing/0001179110-13-017459#line-1","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531563","owner_name":"Mulroy Robert J.","owner_display_name":"Mulroy Robert J.","owner_url":"/insider/0001531563","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33100.0,"shares_display":"33,100","price_per_share":4.4177,"price_display":"4.42","price_state":"stated","total_value":146225.87,"total_display":"146,225.87","total_whole":"146,226","shares_owned_after":989644.0,"shares_owned_after_display":"989,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-04","filed_date":"2013-12-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001274792","name":"MERRIMACK PHARMACEUTICALS INC","url":"/issuer/0001274792","role":"Director, Officer (President and CEO)","n_filings":6,"first_seen":"2013-12-05","last_seen":"2015-03-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001531563","retrieved_at":"2026-08-24T09:18:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}